Mark Forshag

826 total citations
16 papers, 604 citations indexed

About

Mark Forshag is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Mark Forshag has authored 16 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 5 papers in Surgery. Recurrent topics in Mark Forshag's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (8 papers) and Eosinophilic Esophagitis (4 papers). Mark Forshag is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (8 papers) and Eosinophilic Esophagitis (4 papers). Mark Forshag collaborates with scholars based in United States, United Kingdom and Canada. Mark Forshag's co-authors include Frank C. Albers, Héctor Ortega, Steve Yancey, Anand A. Dalal, Xiwu Lin, Laurence Gozalo, Mei Sheng Duh, Marie-Noëlle Robitaille, Patrick Lefèbvre and Urvi Desai and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Mark Forshag

16 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Forshag United States 12 454 411 125 79 67 16 604
Santi Nolasco Italy 16 411 0.9× 382 0.9× 82 0.7× 136 1.7× 75 1.1× 32 554
Tregony Simoneau United States 13 233 0.5× 207 0.5× 111 0.9× 147 1.9× 213 3.2× 36 669
Berta Juliá Spain 13 199 0.4× 135 0.3× 81 0.6× 113 1.4× 69 1.0× 45 505
Frank Trudo United States 16 938 2.1× 819 2.0× 147 1.2× 183 2.3× 108 1.6× 50 1.1k
Pınar Çelik Türkiye 14 144 0.3× 301 0.7× 54 0.4× 50 0.6× 12 0.2× 53 517
Mitesh Patel United Kingdom 15 457 1.0× 429 1.0× 42 0.3× 42 0.5× 29 0.4× 32 694
Madan Roy Canada 6 200 0.4× 174 0.4× 28 0.2× 28 0.4× 47 0.7× 14 369
Stephanie Korrer United States 11 99 0.2× 88 0.2× 93 0.7× 16 0.2× 30 0.4× 22 310
Sanjay Ramakrishnan United Kingdom 9 229 0.5× 227 0.6× 26 0.2× 21 0.3× 32 0.5× 24 379
Ian Johnston United Kingdom 8 131 0.3× 400 1.0× 49 0.4× 4 0.1× 26 0.4× 10 551

Countries citing papers authored by Mark Forshag

Since Specialization
Citations

This map shows the geographic impact of Mark Forshag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Forshag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Forshag more than expected).

Fields of papers citing papers by Mark Forshag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Forshag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Forshag. The network helps show where Mark Forshag may publish in the future.

Co-authorship network of co-authors of Mark Forshag

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Forshag. A scholar is included among the top collaborators of Mark Forshag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Forshag. Mark Forshag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gibson, Peter G., Charlene M. Prazma, Geoffrey Chupp, et al.. (2021). Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions. Respiratory Research. 22(1). 171–171. 36 indexed citations
2.
Ortega, Héctor, Catherine Lemière, Jean‐Pierre Llanos, et al.. (2019). Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial. Allergy Asthma and Clinical Immunology. 15(1). 37–37. 26 indexed citations
3.
Khurana, Sandhya, Jeffrey M. Lyness, Stephen Mallett, et al.. (2019). Association of depressive symptoms with health status and markers of uncontrolled severe asthma. Allergy and Asthma Proceedings. 40(4). 230–239. 5 indexed citations
4.
Menzies‐Gow, Andrew, Mark Forshag, Frank C. Albers, et al.. (2018). Improvement of lung function measured by AM PEF in patients with severe eosinophilic asthma treated with mepolizumab: A combined analysis of the MENSA and MUSCA studies. Journal of Allergy and Clinical Immunology. 141(2). AB16–AB16. 1 indexed citations
5.
Patel, Minal, Valerie G. Press, Lynn B. Gerald, et al.. (2018). Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease: An Official American Thoracic Society Policy Statement. American Journal of Respiratory and Critical Care Medicine. 198(11). 1367–1374. 33 indexed citations
6.
Ortega, Héctor, Andrew Menzies‐Gow, Jean‐Pierre Llanos, et al.. (2018). Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab. Advances in Therapy. 35(7). 1059–1068. 13 indexed citations
7.
Basu, Anirban, Anand A. Dalal, Giorgio Walter Canonica, et al.. (2017). Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype. Expert Review of Pharmacoeconomics & Outcomes Research. 17(2). 121–131. 15 indexed citations
8.
Dalal, Anand A., Mei Sheng Duh, Laurence Gozalo, et al.. (2016). Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma. Journal of Managed Care & Specialty Pharmacy. 22(7). 833–847. 96 indexed citations
9.
Forshag, Mark. (2016). Trials and Tribulations: An Industry Perspective on Conducting Registrational Trials in Alpha-1 Antitrypsin Deficiency. Annals of the American Thoracic Society. 13(Supplement_4). S374–S377. 1 indexed citations
10.
Chastek, Benjamin, Stephanie Korrer, Saurabh Nagar, et al.. (2016). Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. Journal of Managed Care & Specialty Pharmacy. 22(7). 848–861. 97 indexed citations
11.
Lefèbvre, Patrick, Mei Sheng Duh, Marie‐Hélène Lafeuille, et al.. (2016). Burden of systemic glucocorticoid-related complications in severe asthma. Current Medical Research and Opinion. 33(1). 57–65. 55 indexed citations
12.
Lefèbvre, Patrick, Mei Sheng Duh, Marie‐Hélène Lafeuille, et al.. (2015). Acute and chronic systemic corticosteroid–related complications in patients with severe asthma. Journal of Allergy and Clinical Immunology. 136(6). 1488–1495. 158 indexed citations
13.
Patel, Dipen, Xin Gao, Jennifer Stephens, Mark Forshag, & M. Tarallo. (2011). US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host. Journal of Medical Economics. 14(2). 227–237. 17 indexed citations
14.
Phillips, Penny, Mark Forshag, David C. McGiffin, et al.. (1996). Transmission of Mycobacterium Tuberculosis to Recipients of Single Lung Transplants From the Same Donor. American Journal of Respiratory and Critical Care Medicine. 153(3). 1166–1168. 38 indexed citations
15.
Forshag, Mark, et al.. (1993). Pulmonary Atelectasis and Dysphagia in a 69-Year-Old Cachectic Man. CHEST Journal. 103(3). 917–919. 1 indexed citations
16.
Forshag, Mark & Allen D. Cooper. (1992). POSTOPERATIVE CARE OF THE THORACOTOMY PATIENT. Clinics in Chest Medicine. 13(1). 33–45. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santi Nolasco Breakdown of academic impact, for papers by Tregony Simoneau Breakdown of academic impact, for papers by Berta Juliá Breakdown of academic impact, for papers by Frank Trudo Breakdown of academic impact, for papers by Pınar Çelik Breakdown of academic impact, for papers by Mitesh Patel Breakdown of academic impact, for papers by Madan Roy Breakdown of academic impact, for papers by Stephanie Korrer Breakdown of academic impact, for papers by Sanjay Ramakrishnan Breakdown of academic impact, for papers by Ian Johnston
Rankless by CCL
2026